Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

16.92

+0.02 (0.12%)

Aug 6, 2026, 4:00 PM EDT - Market closed

Theravance Biopharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	109.78	107.46	64.38	57.42	51.35	55.31
Revenue Growth	68.20%	66.92%	12.12%	11.84%	-7.17%	-23.03%
Gross Profit	109.78	107.46	64.38	57.42	51.35	55.31
Operating Income	1.35	-3.6	-46.95	-56.04	-91.96	-257.78
Net Income	-4.93	129.25	-44.61	-55.19	872.14	-199.43
Earnings Per Share	2.20	2.06	-1.15	-1.00	11.85	-2.87
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	74.96	64.38	57.2	51.12	55.27
Europe	32.5	-	0.22	0.22	0.04
Total	107.46	64.38	57.42	51.35	55.31

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	394.67	315.36	88.35	102.43	327.48	173.47
Total Debt	40.5	42.7	49.82	49.16	52.16	669.52
Net Cash (Debt)	354.16	272.65	38.53	53.27	275.32	-496.05
Net Cash Growth	328.25%	607.64%	-27.67%	-80.65%	-	-
Net Cash Per Share	6.83	5.29	0.79	0.96	3.74	-7.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	268.78	238.54	-11.54	-27	-186.99	-207.86
Capital Expenditures	-	-0.04	-0.33	-2.49	-0.57	-3.41
Free Cash Flow	268.78	238.5	-11.87	-29.49	-187.56	-211.26
Free Cash Flow Growth	726.36%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	1.23%	-3.35%	-72.92%	-97.58%	-179.09%	-466.06%
Pretax Margin	-5.89%	120.27%	-69.30%	-85.80%	-180.76%	-479.51%
Profit Margin	1.43%	120.27%	-69.30%	-85.80%	-180.76%	-479.24%
FCF Margin	244.85%	221.93%	-18.43%	-51.35%	-365.29%	-381.96%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	7.65	9.08	-	-	0.95	-
Forward PE	7.62	25.83	29.96	29.96	29.96	-
P/FCF Ratio	3.26	4.01	-	-	-	-
PS Ratio	7.99	8.89	7.23	9.41	14.25	14.87